Merck says study shows COVID-19 drug causes quick reduction in virus

Reuters | Washington DC | Updated: 06-03-2021 11:43 IST | Created: 06-03-2021 11:40 IST
Merck says study shows COVID-19 drug causes quick reduction in virus
Representative image Image Credit:

U.S. drugmaker Merck & Co Inc said on Saturday the experimental antiviral drug molnupiravir it is developing with Ridgeback Bio showed a quicker reduction in the infectious virus in its phase 2a study among participants with early COVID-19. "The secondary objective findings in this study, of a quicker decrease in infectious virus among individuals with early COVID-19 treated with molnupiravir, are promising," said William Fischer, Associate Professor of Medicine at the University of North Carolina School of Medicine, in a statement from the companies.

The antiviral is being currently tested in a Phase 2/3 trial that is set to be completed in May. Merck decided to focus on therapeutics after its two COVID-19 vaccines failed to generate desired immune responses, prompting it to abandon the program in January.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)



Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

World Water Day sees crises of inequality in countries both rich and poor

... ...


Latest News

WHO calls for equitable access to healthcare to every Chagas disease patient

Today on World Chagas Disease Day, the World Health Organization WHO has called for comprehensive and equitable access to health care and services to everyone affected by Chagas disease. An estimated 6 to 7 million people worldwide are infe...

'Tika Utsav': India's COVID-19 vaccination coverage crosses 11.43 crore mark

The cumulative number of COVID-19 vaccine doses administered in the country has surpassed the 11.43 crore mark on the fourth day of the Tika Utsav or vaccination festival, with more than 31.39 lakh vaccine doses being administered till 8 pm...

The bell for Mamata s departure has already rung : Nadda

BJP president J P Nadda Wednesday hit out at Chief Minister Mamata Banerjee for the language she used against BJP top leaders and for disrespecting the culture of Bengal and said the bell for her departure has already rung.Contending that t...

COVID-19: Muzaffarnagar reports 399 more cases, 2 deaths

Uttar Pradeshs Muzaffarnagar Wednesday reported 399 more COVID-19 cases, and two deaths, pushing the overall figures to 10,563 infections and 125 fatalities, officials said.With this, the number of active cases has reached 1,424.As many as ...

Give Feedback